An early phase II clinical trial of remoxipride in schizophrenia with measurement of plasma neuroleptic activity.
Chouinard
G
G
Turnier
L
L
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017330:Remoxipride; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D001549:Benzamides; D017330:Remoxipride